H3L Stock Overview
An investment holding company, provides supplies and software as a service (SaaS) to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for patients with chronic condition management. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
ClouDr Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.14 |
| 52 Week High | HK$0.69 |
| 52 Week Low | HK$0.12 |
| Beta | 0.35 |
| 1 Month Change | -4.08% |
| 3 Month Change | -46.59% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -92.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| H3L | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | 0.2% | 0.7% |
| 1Y | n/a | 14.8% | 8.4% |
Return vs Industry: Insufficient data to determine how H3L performed against the German Healthcare industry.
Return vs Market: Insufficient data to determine how H3L performed against the German Market.
Price Volatility
| H3L volatility | |
|---|---|
| H3L Average Weekly Movement | 9.2% |
| Healthcare Industry Average Movement | 4.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 12.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: H3L's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: H3L's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 1,558 | Ming Kuang | www.cloudr.cn |
ClouDr Group Limited, an investment holding company, provides supplies and software as a service (SaaS) to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for patients with chronic condition management. The company’s integrated in-hospital solution offers chronic condition management solution to hospitals including hospital SaaS and proprietary artificial intelligence of things devices; and integrated out-of-hospital solution consists of pharmacy solution and individual chronic condition management solution. It also offers pharmacy solution, which includes pharmacy SaaS, pharmacy supplies, and sells stock keeping units based on its SaaS network in pharmacies; pharmacy SaaS that enables in-store, real-time online consultation, and prescription services; identifies pharmacy supplies sales opportunities based on the insights generated from prescription services; and retail and inventory management functions for pharmacies.
ClouDr Group Limited Fundamentals Summary
| H3L fundamental statistics | |
|---|---|
| Market cap | €87.15m |
| Earnings (TTM) | -€37.51m |
| Revenue (TTM) | €532.00m |
0.2x
P/S Ratio-2.3x
P/E RatioIs H3L overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| H3L income statement (TTM) | |
|---|---|
| Revenue | CN¥4.01b |
| Cost of Revenue | CN¥3.14b |
| Gross Profit | CN¥872.81m |
| Other Expenses | CN¥1.16b |
| Earnings | -CN¥282.90m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.48 |
| Gross Margin | 21.75% |
| Net Profit Margin | -7.05% |
| Debt/Equity Ratio | 33.3% |
How did H3L perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 03:00 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ClouDr Group Limited is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Liping Zhao | China International Capital Corporation Limited |
| null null | CMB International Securities Limited |
| Jessie Lu | HSBC |